Completed
Benralizumab in Patients With Inadequate Response to Anti-IL5 Monoclonal Antibody Therapies
NCT03470311
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +10 more
- Locations
-
- Firestone Institute for Respiratory Health, Research - St. Joseph's Healthcare Hamilton, Ontario, Canada